Green chemistry in medicinal chemistry: A review on sustainable approaches to the synthesis of biologically active compounds

The pharmaceutical industry's commitment to sustainability is reshaping drug development, centering on green chemistry principles to minimize environmental impact without compromising drug efficacy. This review explores transformative green chemistry approaches, emphasizing atom economy, waste reduction, and renewable feedstocks in synthesizing biologically active compounds. Key advancements such as biocatalysis, flow chemistry, and safer solvent alternatives demonstrate a path to efficient, lower-impact drug synthesis. These sustainable strategies, while challenged by regulatory and industrial constraints, showcase significant potential to reduce the pharmaceutical carbon footprint and environmental toxicity. Through the integration of green methodologies, the industry can address pressing ecological challenges, improve public health, and foster a paradigm shift toward sustainable pharmaceutical production.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-30
DOI
https://doi.org/10.5281/zenodo.15094310
Primary Topic
Chemistry and Chemical Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Green chemistry in medicinal chemistry: A review on sustainable approaches to the synthesis of biologically active compounds

Zenodo (CERN European Organization for Nuclear Research)
Chemistry and Chemical Engineering
article

Green chemistry in medicinal chemistry: A review on sustainable approaches to the synthesis of biologically active compounds

article en

Abstract

The pharmaceutical industry's commitment to sustainability is reshaping drug development, centering on green chemistry principles to minimize environmental impact without compromising drug efficacy. This review explores transformative green chemistry approaches, emphasizing atom economy, waste reduction, and renewable feedstocks in synthesizing biologically active compounds. Key advancements such as biocatalysis, flow chemistry, and safer solvent alternatives demonstrate a path to efficient, lower-impact drug synthesis. These sustainable strategies, while challenged by regulatory and industrial constraints, showcase significant potential to reduce the pharmaceutical carbon footprint and environmental toxicity. Through the integration of green methodologies, the industry can address pressing ecological challenges, improve public health, and foster a paradigm shift toward sustainable pharmaceutical production.

Zenodo (CERN European Organization for Nuclear Research)
University of Ilorin (NG), University of Abuja (NG)
Industry, innovation and infrastructure
Openalex Percentile: Top 75%
Chemistry and Chemical Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.